Multiple sclerosis guideline from NICE
The National Institute for Health and Care Excellence (NICE) has launched a new guideline for the management of mutliple sclerosis in primary and secondary care (CG186). The guideline can be accessed on the NICE website.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066771
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com